Article Information
History
- March 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julien Haemmerli1,*,†,
- Lukas Sveikata2,*,
- Aria Nouri1,
- Adrien May1,
- Kristof Egervari3,
- Christian Freyschlag4,
- Johannes A. Lobrinus3,
- Denis Migliorini5,
- Shahan Momjian1,
- Nicolae Sanda2,
- Karl Schaller1,
- Sebastien Tran6,
- Jacky Yeung7 and
- Philippe Bijlenga1
- 1Department of Clinical Neurosciences, Division of Neurosurgery, Geneva University Hospitals, Geneva Switzerland
- 2Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospitals, Geneva Switzerland
- 3Department of Pathology and Immunology, Division of Clinical Pathology, Geneva University Hospitals, Geneva Switzerland
- 4Department of Neurosurgery, Medical University of Innsbruck, Innsbruck Austria
- 5Department of Oncology, Geneva University Hospitals, Geneva Switzerland
- 6Department of Radiation Oncology, Geneva University Hospitals, Geneva Switzerland
- 7Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA
- ↵†Corresponding author: Julien Haemmerli, MD, Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland, Julien.haemmerli{at}hcuge.ch, +41-79 553 37 74
↵* Julien Haemmerli and Lukas Sveikata contributed equally to this work.
Posted March 24, 2023.
ChatGPT in glioma patient adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?
